Tikvah Therapeutics Names Jack W. Callicutt Vice President and Chief Financial Officer
ATLANTA, Aug. 9, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc., a biopharmaceutical company focused on new treatment options to better manage central nervous system diseases, announced today the appointment of Jack W. Callicutt to the position of Vice President and Chief Financial Officer, effective August 6, 2007.